Determinants of neurosurgical outcome in pituitary tumors
MJ Barahona, L Sojo, AM Wägner, F Bartumeus… - Journal of …, 2005 - Springer
Objective: Neurosurgery is one of the main therapies for pituitary tumors; optimising outcome
is highly desirable for the patient and the health system. We have analysed predictors of …
is highly desirable for the patient and the health system. We have analysed predictors of …
Update on prolactinomas. Part 2: treatment and management strategies
The authors present an update on the various treatment modalities and discuss
management strategies for prolactinomas. Prolactinomas are the most common type of …
management strategies for prolactinomas. Prolactinomas are the most common type of …
Gender-related differences in prolactin secretion in pituitary prolactinomas
H Nishioka, J Haraoka, K Akada, S Azuma - Neuroradiology, 2002 - Springer
In pituitary prolactinomas, serum prolactin (PRL) levels usually parallel the tumor size. We
conducted a retrospective study to determine differences in PRL production between men …
conducted a retrospective study to determine differences in PRL production between men …
Temozolomide in the treatment of an invasive prolactinoma resistant to dopamine agonists
LM Neff, M Weil, A Cole, TR Hedges, W Shucart… - Pituitary, 2007 - Springer
Prolactinomas are common tumors of the anterior pituitary gland. While conventional
therapies, including dopamine agonists, transsphenoidal surgery and radiotherapy, are …
therapies, including dopamine agonists, transsphenoidal surgery and radiotherapy, are …
Treatment and long-term follow-up results of prolactin secreting pituitary adenomas.
C Scamoni, C Balzarini, G Crivelli… - Journal of Neurosurgical …, 1991 - europepmc.org
The authors have reported data on a retrospective study, carried out in order to evaluate the
short-and the long-term follow-up results of transsphenoidal microsurgery for prolactin …
short-and the long-term follow-up results of transsphenoidal microsurgery for prolactin …
Prolactinoma manifesting with symptomatic hydrocephalus
OM Zikel, JLD Atkinson, DL Hurley - Mayo Clinic Proceedings, 1999 - Elsevier
Prolactinomas are the most common secretory adenomas of pituitary origin. They typically
manifest with symptoms referable to their endocrinologic effects or, if of sufficient size, to …
manifest with symptoms referable to their endocrinologic effects or, if of sufficient size, to …
What are the markers of aggressiveness in prolactinomas? Changes in cell biology, extracellular matrix components, angiogenesis and genetics
A Gurlek, N Karavitaki, O Ansorge… - European Journal of …, 2007 - academic.oup.com
Prolactinoma is the most common pituitary tumour in adults. Macroprolactinomas,
particularly in men, may occasionally exhibit a very aggressive clinical course as evidenced …
particularly in men, may occasionally exhibit a very aggressive clinical course as evidenced …
Aggressive pituitary tumors.
LS Blevins Jr, DK Verity, G Allen - Oncology (Williston Park, NY), 1998 - europepmc.org
Although almost all pituitary tumors are benign adenomas, a surprisingly large number of
these tumors invade tissues outside of the pituitary gland. Such invasion, by itself, is not …
these tumors invade tissues outside of the pituitary gland. Such invasion, by itself, is not …
[HTML][HTML] Diagnosis and management of prolactinomas: current challenges
S Petersenn, A Giustina - Pituitary, 2020 - Springer
Prolactinoma is the most frequent pituitary adenoma type, accounting for 40–66% in
epidemiological studies [1]. The estimated prevalence in various populations ranges from …
epidemiological studies [1]. The estimated prevalence in various populations ranges from …
Nonfunctioning pituitary tumors
ME Molitch - Handbook of clinical neurology, 2014 - Elsevier
Clinically nonfunctioning adenomas range from being completely asymptomatic, and
therefore detected either at autopsy or as incidental findings on head MRI or CT scans …
therefore detected either at autopsy or as incidental findings on head MRI or CT scans …